Clinical trial
Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-prone Diabetes
NCT03566524 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-prone Diabetes
- Lead sponsor
- Baylor College of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- June 30, 2022
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ketosis prone diabetes